Cardiovascular Devices are used in treating diseases related to the heart and the circulatory system. Inferior Vena Cava Filter (IVCF) is a metallic device used to prevent blood clots from traveling to the lungs. GlobalData uses proprietary data and analytics to provide a comprehensive report on the inferior vena cava filters (ivcf) market in France. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the inferior vena cava filters (ivcf) market in France was Becton Dickinson and Co followed by Mermaid Medical, LifeTech Scientific, B. Braun Melsungen, ALN implants chirurgicaux, Merit Medical Systems, Argon Medical Devices, Cook Group, Cardinal Health and Boston Scientific.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
IVCF is inserted into a large vein called the inferior vena cava (which carries blood from the lower extremities to the heart). The IVC filter traps blood clots before they reach the lungs. It is commonly used as a preventive measure in cases where Deep vein thrombosis and pulmonary embolism have been diagnosed or as a prophylactic device in cases where the risk of developing venous thromboembolism is high and there is a contraindication for anticoagulants. The use of IVC filters can prevent PE, but it does not restrict blood clot formation. IVC filters are made of non-ferromagnetic materials [cobalt chromium alloy, stainless steel, titanium, nickel-titanium (nitinol)]. Permanent, Retrievable IVC filters and IVCF retrieval devices are included in inferior vena cava filters. Permanent Inferior Vena Cava Filters (IVCF) once inserted cannot be removed or repositioned. Retrievable Inferior Vena Cava Filters (IVCF) once inserted can be retrieved or repositioned up to a certain point in time. Optional Retrievable Inferior Vena Cava Filters are used to prevent pulmonary embolism when anticoagulation is ineffective. Temporary Retrievable Inferior Vena Cava Filters are used to prevent the risk of PE for a short duration and should be ideally retrieved within 30 to 60 days. IVCF retrieval devices are used for the removal of retrievable IVC filters from the vena cava.
The inferior vena cava filters (ivcf) market in France can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size inferior vena cava filters (ivcf) in France, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
